|
Market Closed -
NYSE
00:10:00 25/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 33.52 USD | -1.71% |
|
-8.28% | +3.73% |
| Current month | -13.95% | ||
| 1 month | -15.19% |
Investment objective
The iShares Neuroscience and Healthcare ETF (the Fund) seeks to track the investment results of an index composed of U.S. and non-U.S. companies that could benefit from the growth and innovation in neuroscience.
Off-Hours Price |
Change |
YTD change |
Weight | ||
|---|---|---|---|---|---|
 | 196.03USD | +1.33% | +7.33% | 4.89% | |
| 281.79USD | -0.12% | -4.39% | 4.75% | |
| 38.06USD | +4.10% | -15.08% | 3.98% | |
| 62.28USD | -0.10% | -18.01% | 3.93% | |
| 48.61USD | -2.49% | +10.35% | 3.91% | |
| 22.18USD | -12.78% | -16.96% | 3.89% | |
| 226.36USD | -0.51% | +28.62% | 3.88% | |
| 40.79USD | -3.18% | +45.78% | 3.79% | |
| 138.94USD | -0.39% | -2.04% | 3.65% | |
In partnership with
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/09/26 | $33.53 | -1.71% | 368 |
| 23/09/26 | $34.11 | -4.37% | 2,888 |
| 22/09/26 | $35.67 | +0.98% | 3,823 |
| 21/09/26 | $35.32 | +0.38% | 2,149 |
| 18/09/26 | $35.19 | -3.73% | 818 |
Description
| US46436E3532 | |
|---|---|
| Total Expense Ratio | 0.0047 |
| Asset Class | Stocks |
| Currency | |
| Provider | |
| Underlying | NYSE FactSet Global Neuro Biopharma and MedTech Net Index - USD |
| Autres ETFs | |
Features and characteristics
| Dividend Policy | Distribution |
|---|---|
| Replication Method | Physique |
| Jurisdiction | |
| Date of creation |
24/08/2022
|
AuM evolution - 12/08/2026
| AuM (USD) | 9.14M |
|---|---|
| AuM 1M | 9.14M |
| AuM 3 months | 9.14M |
| AuM 6 months | 9.14M |
| AuM 12 months | 9.14M |
- Stock Market
- ETF
- IBRN ETF
Select your edition
All financial news and data tailored to specific country editions
